Drug Trial Radar · NCT07680790
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
850
Planned (sponsor's estimate)
Start
Sep 8, 2026
Primary completion
Dec 30, 2031
Study completion Dec 30, 2031
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jul 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate izalontamab brengitecan (iza-bren) combined with osimertinib in participants with previously untreated, locally advanced or metastatic EGFR-mutant NSCLC, compared to osimertinib alone or osimertinib combined with platinum-based chemotherapy
Conditions
- Non-Small Cell Lung Cancer
Interventions
Iza-brenDrug
Specified dose on specified days
OsimertinibDrug
Specified dose on days
PemetrexedDrug
Specified dose on specified days
CarboplatinDrug
Specified dose on specified days
CisplatinDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS) using blinded independent central review (BICR) assessment as defined by Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1)Time frame: Up to approximately 3 years
Locations
205 sites in 16 countries. Site status is shown where the registry gives one.
Local Institution - 0212
Beverly Hills, California · Not yet recruiting
Local Institution - 0504
Fullerton, California · Not yet recruiting
Local Institution - 0357
La Jolla, California · Not yet recruiting
Rocky Mountain Cancer Centers
Boulder, Colorado · Recruiting
Local Institution - 0161
Washington D.C., District of Columbia · Not yet recruiting
Local Institution - 0527
Fort Myers, Florida · Not yet recruiting
Local Institution - 0366
Orlando, Florida · Not yet recruiting
Cancer Care Centers of Brevard - Rockledge
Palm Bay, Florida · Recruiting
Local Institution - 0526
St. Petersburg, Florida · Not yet recruiting
Local Institution - 0524
West Palm Beach, Florida · Not yet recruiting
Local Institution - 0185
Chicago, Illinois · Not yet recruiting
Local Institution - 0207
Ottawa, Illinois · Not yet recruiting
Local Institution - 0503
Baltimore, Maryland · Not yet recruiting
Local Institution - 0537
Baltimore, Maryland · Not yet recruiting
Local Institution - 0523
Silver Spring, Maryland · Not yet recruiting
Local Institution - 0521
Edina, Minnesota · Not yet recruiting
Local Institution - 0364
Saint Paul, Minnesota · Not yet recruiting
Washington University School Of Medicine
St Louis, Missouri · Recruiting
Local Institution - 0402
Omaha, Nebraska · Not yet recruiting
Local Institution - 0290
Lebanon, New Hampshire · Not yet recruiting
Local Institution - 0183
New Brunswick, New Jersey · Not yet recruiting
Local Institution - 0153
New York, New York · Not yet recruiting
Local Institution - 0157
The Bronx, New York · Not yet recruiting
Local Institution - 0385
Charlotte, North Carolina · Not yet recruiting
Local Institution - 0438
Sandusky, Ohio · Not yet recruiting
Local Institution - 0404
Portland, Oregon · Not yet recruiting
Local Institution - 0487
Easton, Pennsylvania · Not yet recruiting
Local Institution - 0200
Sioux Falls, South Dakota · Not yet recruiting
Local Institution - 0199
Memphis, Tennessee · Not yet recruiting
Texas Oncology
Beaumont, Texas · Recruiting
Texas Oncology - DFW
Dallas, Texas · Recruiting
Texas Oncology - San Antonio
San Antonio, Texas · Recruiting
Local Institution - 0411
Salt Lake City, Utah · Not yet recruiting
Local Institution - 0165
Fairfax, Virginia · Not yet recruiting
Local Institution - 0530
Fairfax, Virginia · Not yet recruiting
Shenandoah Oncology, P.C. (Shenandoah Oncology Associates, P.C.)
Winchester, Virginia · Recruiting
Local Institution - 0283
Seattle, Washington · Not yet recruiting
Local Institution - 0502
Morgantown, West Virginia · Not yet recruiting
Local Institution - 0086
Buenos Aires, Argentina · Not yet recruiting
Local Institution - 0432
Buenos Aires, Argentina · Not yet recruiting
Showing 40 of 205 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.